Inve India ▾

Cityman share price & results

Cityman Limited

Results to
Sept 2016
Ownership as of
Jun 2026
Start an Inve Case

Company research is public. Sign in to keep your own companies, notes and cases.

Reported

The figures, each with its period

Each figure keeps its basis and period; nothing is filled in.

MetricValueChangeBasisPeriodNote
Revenue0.00 ₹ crore—Quarterly, as filedQuarter to Sept 2016Revenue from operations as filed. The year-earlier figure was zero or a loss, so no percentage is shown.
Operating marginUnavailable—Operating profit / revenueQuarter to Sept 2016Not in the filed figures for the quarter to sept 2016. No older figure is substituted.
Net profit-0.11 ₹ crore—Quarterly, as filedQuarter to Sept 2016Profit after tax as filed. The year-earlier figure was zero or a loss, so no percentage is shown.
Return on equity4.88 %+0.0 ptsFY Mar 2026 vs FY Mar 2025Trailing twelve monthsTTM to Jun 2026Adjusted profit attributable to owners ÷ average owners’ equity.
Free cash flow marginUnavailable—Fiscal yearFY ending Mar 2026Not in the analysed materials. No older figure is substituted.
Revenue growth (YoY)Unavailable—Trailing twelve monthsTTM to Jun 2026Not in the analysed materials. No older figure is substituted.

Source: Inve data from filed results; ratios from the Screener-verified panel · to Sept 2016

Price

₹13.78 0.00% · ₹0

Last close 16 Oct 2026 · NSE · INR

Performance −8.2% 1Y

₹12.0₹14.0₹16.0Oct 25Dec 25Jan 26Mar 26Apr 26Jun 26Jul 26Aug 26Oct 26

1Y: ₹15.01 on 15 Oct 2025 → ₹13.78. High ₹16.6 (18 Nov 2025), low ₹11.1 (5 Jan 2026).

Previous close
₹13.78
Market cap
₹17 Cr
52-week range
₹11.1 – ₹16.6
One year
−8.19%
Return on equity (TTM to Jun 2026)
4.88%

Overview

Symbol
NSE:CITYMAN
Exchange
NSE
Currency
INR

Your own record

Start an Inve Case for Cityman Limited

Free account: one company. Everything above stays public.

Write why you follow Cityman Limited and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.